Asianet NewsableAsianet Newsable

Union Health Minister Mandaviya meets WHO chief scientist Dr Soumya Swaminathan over WHO's approval of Covaxin

 A week ago, Bharat Biotech received Good Manufacturing Practices (GMP) compliance certificate from Hungary in the manufacturing of Covaxin.

Union Health Minister Mandaviya meets WHO chief scientist Dr Soumya Swaminathan over WHO's approval of Covaxin-dnm
Author
Bengaluru, First Published Aug 12, 2021, 6:56 PM IST
  • Facebook
  • Twitter
  • Whatsapp

Union Health Minister Mansukh Mandaviya on Thursday met WHO Chief Scientist Dr Soumya Swaminathan and discussed about the global health body’s approval for India’s indigenous Covid-19 vaccine Covaxin manufactured by Bharat Biotech.

“Held a meeting with Dr Soumya Swaminathan, Chief Scientist of @WHO. We had a productive discussion on WHO’s approval of @BharatBiotech’s COVAXIN. @DoctorSoumya also appreciated India’s efforts for the containment of #COVID19,” Mandaviya tweeted.

A week ago, Bharat Biotech received Good Manufacturing Practices (GMP) compliance certificate from Hungary in the manufacturing of Covaxin.

Bharat Biotech statement read, Bharat Biotech achieved another significant milestone in innovating and manufacturing vaccines at global quality standards and moving forward in the ongoing fight against the Covid-19 pandemic.

All documents required for Emergency Use Listing (EUL) were submitted to WHO by Bharat Biotech for Covaxin as of July 9 and the review process by the agency had commenced, Minister of State for Health Bharati Pravin Pawar informed Rajya Sabha.

Responding to a question on whether it has come to the notice of the government that Covid-19 vaccine Covaxin used in India is not recognised by many countries, Pawar had said the government is aware that Covaxin at present is not part of WHO Emergency Use Listing (EUL).

The review process by WHO has commenced. WHO usually takes up to six weeks to decide on Emergency Use Listing (EUL) submissions, she said in a written reply.

Covaxin has already received emergency use authorization in 16 countries, including Brazil, Mexico, Philippines and Iran. Covaxin is among three vaccines currently being used in the country for the nationwide inoculation drive in India. The other two vaccines are Serum Institute of India's Covishield and Russia's Sputnik.

NOTE: Asianet News humbly requests everyone to wear masks, sanitize, maintain social distancing and get vaccinated as soon as eligible. Together we can and will break the chain #ANCares #IndiaFightsCorona  

Follow Us:
Download App:
  • android
  • ios